References
- UrowitzMGladmanDDIbañezDChanges in quality of life in the first 5 years of disease in a multicenter cohort of patients with systemic lupus erythematosusArthritis Care Res201466913741379
- JollyMHow does quality of life of patients with systemic lupus erythematosus compare with that of other common chronic illnesses?J Rheumatol20053291706170816142864
- PlantingaLLimSSBowlingCBDrenkardCAssociation of age with health-related quality of life in a cohort of patients with systemic lupus erythematosus: the Georgians Organized Against Lupus studyLupus Sci Med201631e00016127547440
- FortinPRAbrahamowiczMNevilleCImpact of disease activity and cumulative damage on the health of lupus patientsLupus1998721011079541094
- ThumbooJFongKYChanSPA prospective study of factors affecting quality of life in systemic lupus erythematosusJ Rheumatol20002761414142010852263
- McelhoneKAbbottJTehLSA review of health related quality of life in systemic lupus erythematosusLupus2006151063364317120589
- MahieuMYountSRamsey-GoldmanRPatient-Reported Outcomes in Systemic Lupus ErythematosusRheum Dis Clin North Am201642225326327133488
- HollowayLHumphreyLHeronLPatient-reported outcome measures for systemic lupus erythematosus clinical trials: a review of content validity, face validity and psychometric performanceHealth Qual Life Outcomes20141211625048687
- NordmarkGBengtssonCLarssonAEffects of dehydroepiandrosterone supplement on health-related quality of life in glucocorticoid treated female patients with systemic lupus erythematosusAutoimmunity200538753154016373258
- TseKCTangCSLioWILamMFChanTMQuality of life comparison between corticosteroid- and-mycofenolate mofetil and corticosteroid- and-oral cyclophosphamide in the treatment of severe lupus nephritisLupus200615637137916830884
- StrandVCrawfordBImprovement in health-related quality of life in patients with SLE following sustained reductions in anti-dsDNA antibodiesExpert Rev Pharmacoecon Outcomes Res20055331732619807601
- StrandVPetriMKalunianKEpratuzumab for patients with moderate to severe flaring SLE: health-related quality of life outcomes and corticosteroid use in the randomized controlled ALLEVIATE trials and extension study SL0006Rheumatology201453350251124273022
- StrandVLevyRACerveraRImprovements in health-related quality of life with belimumab, a B-lymphocyte stimulator-specific inhibitor, in patients with autoantibody-positive systemic lupus erythematosus from the randomised controlled BLISS trialsAnn Rheum Dis2014738384423524886
- StollTGordonCSeifertBConsistency and validity of patient administered assessment of quality of life by the MOS SF-36; its association with disease activity and damage in patients with systemic lupus erythematosusJ Rheumatol1997248160816149263159
- ColangeloKJPopeJEPeschkenCThe minimally important difference for patient reported outcomes in systemic lupus erythematosus including the HAQ-DI, pain, fatigue, and SF-36J Rheumatol200936102231223719723907
- DevilliersHAmouraZBesancenotJFResponsiveness of the 36-item Short Form Health Survey and the Lupus Quality of Life questionnaire in SLERheumatology201554594094925361539
- ToumaZGladmanDDIbañezDUrowitzMBIs there an advantage over SF-36 with a quality of life measure that is specific to systemic lupus erythematosus?J Rheumatol20113891898190521724700
- McelhoneKAbbottJSuttonCSensitivity to Change and Minimal Important Differences of the LupusQoL in Patients With Systemic Lupus ErythematosusArthritis Care Res2016681015051513
- NantesSGStrandVSuJToumaZComparison of the Sensitivity to Change of the 36-Item Short Form Health Survey and the Lupus Quality of Life Measure Using Various Definitions of Minimum Clinically Important Differences in Patients With Active Systemic Lupus ErythematosusArthritis Care Res2018701125133
- AggarwalRWilkeCTPickardASPsychometric properties of the EuroQol-5D and Short Form-6D in patients with systemic lupus erythematosusJ Rheumatol20093661209121619369452
- KatzPPedroSMichaudKPerformance of the PROMIS 29-Item Profile in Rheumatoid Arthritis, Osteoarthritis, Fibromyalgia, and Systemic Lupus ErythematosusArthritis care & research2017691312132128029753
- KasturiSSzymonifkaJBurketJCValidity and Reliability of Patient Reported Outcomes Measurement Information System Computerized Adaptive Tests in Systemic Lupus ErythematosusJ Rheumatol20174471024103128412708
- DevilliersHBonithon-KoppCJollyMThe lupus impact tracker is responsive to changes in clinical activity measured by the systemic lupus erythematosus responder indexLupus201726439640227587460
- LeongKPKongKOThongBYDevelopment and preliminary validation of a systemic lupus erythematosus-specific quality-of-life instrument (SLEQOL) Rheumatology (Oxford)2005441267127615797980
- KasitanonNWangkaewSPuntanaSSukitawutWLeongKPLouthrenoo WTan Tock Seng Hospital Lupus Study GroupThe reliability, validity and responsiveness of the Thai version of Systemic Lupus Erythematosus Quality of Life (SLEQOL-TH) instrumentLupus201322328929623358871
- DaleboudtGMBergerSPBroadbentEKapteinAAHealth-related quality of life in patients with systemic lupus erythematosus and proliferative lupus nephritisPsychol Health Med201116439340421749237
- GiangrecoDDevilliersHAnnapureddyNBlockJAJollyMLupus Impact Tracker is responsive to physician and patient assessed changes in systemic lupus erythematosusLupus201524141486149126162686